Development
Biogen Inc.
BIIB
$138.60
$3.662.71%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 249.70M | -68.10M | 591.60M | 387.90M | 550.40M |
| Total Depreciation and Amortization | 140.10M | 125.00M | 117.40M | 112.30M | 119.80M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 270.80M | 221.10M | -91.10M | 139.20M | 142.30M |
| Change in Net Operating Assets | -648.10M | 314.40M | -130.90M | -184.10M | -987.50M |
| Cash from Operations | 12.50M | 592.40M | 487.00M | 455.30M | -175.00M |
| Capital Expenditure | -65.20M | -74.20M | -71.00M | -66.60M | -86.40M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00 |
| Cash Acquisitions | -590.50M | -6.34B | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.40M | 4.67B | -682.50M | -886.40M | -54.70M |
| Cash from Investing | -652.30M | -1.74B | -753.50M | -953.00M | -141.10M |
| Total Debt Issued | 0.00 | 997.20M | -- | -- | -- |
| Total Debt Repaid | -650.00M | -159.90M | -- | -- | 0.00 |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3.90M | 11.30M | -9.80M | -43.40M | -7.40M |
| Cash from Financing | -646.10M | 848.60M | -9.80M | -43.40M | -7.40M |
| Foreign Exchange rate Adjustments | 47.90M | -28.70M | -4.10M | 20.00M | 67.20M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.24B | -329.90M | -280.40M | -521.10M | -256.30M |